Program
tivoxavir marboxil
Its studies are mostly in Influenza, Human, led by Traws Pharma.
Furthest: phase 2, since Aug 4, 20254 company-led studies, 3 open or runningNext primary completion: Nov 2026 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Traws Pharma | 43 open or running | phase 2since Aug 4, 2025 | Dec 16, 2024 | Nov 2026phase 2 · NCT07503405 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 16, 2024First study: phase 1 study in Healthy Volunteer StudyFirst studyNCT06757738 · 66 enrolled · Australia
- Aug 4, 2025Phase 2 study in Influenza, HumanNCT07371650 · 105 enrolled · Australia
- Mar 25, 2026Phase 2 study in Influenza, HumanNCT07503405 · 165 planned · United Kingdom
- Apr 6, 2026Phase 1 study in Influenza, HumanNCT07526506 · 32 planned · Australia
Ahead
- Nov 2026Primary completion: phase 2 study in Influenza, HumanNCT07503405
- Dec 2026Primary completion: phase 2 study in Influenza, HumanNCT07371650
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07526506Influenza, Human · Australia | 1 | Recruiting | Sep 2026 | 32 |
| NCT07503405Influenza, Human · United Kingdom | 2 | Not yet recruiting | Nov 2026 | 165 |
| NCT07371650Influenza, Human · Australia | 2 | Active, not recruiting | Dec 2026 | 105 |
| NCT06757738Healthy Volunteer Study · Australia | 1 | Completed | Jan 16, 2025 | 66 |
How it is read
Names in the registry
- “TRX-100”, 4 entries
Conditions, from the studies’ own filings
- Influenza, Human, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.